WO2022124148A1 - 核酸検出方法、化合物、及び蛍光プローブ - Google Patents

核酸検出方法、化合物、及び蛍光プローブ Download PDF

Info

Publication number
WO2022124148A1
WO2022124148A1 PCT/JP2021/043996 JP2021043996W WO2022124148A1 WO 2022124148 A1 WO2022124148 A1 WO 2022124148A1 JP 2021043996 W JP2021043996 W JP 2021043996W WO 2022124148 A1 WO2022124148 A1 WO 2022124148A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
nucleic acid
stranded nucleic
fluorescence
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2021/043996
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
隆 坂本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakayama University
Original Assignee
Wakayama University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakayama University filed Critical Wakayama University
Priority to JP2022568211A priority Critical patent/JP7773214B2/ja
Priority to EP21903252.1A priority patent/EP4261209A4/en
Priority to US18/266,187 priority patent/US20240301472A1/en
Publication of WO2022124148A1 publication Critical patent/WO2022124148A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/12—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being branched "branched" means that the substituent on the polymethine chain forms a new conjugated system, e.g. most trinuclear cyanine dyes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Definitions

  • the present disclosure relates to nucleic acid detection methods, compounds, and fluorescent probes.
  • This application claims priority based on Japanese Application No. 2020-206368 filed on December 11, 2020, and incorporates all the contents described in the Japanese application.
  • Patent Document 1 discloses a compound as a DNA probe.
  • a typical compound disclosed in Patent Document 1 is quinone cyanine-dithiazole (QCy-DT).
  • QCy-DT is a "donor-two-acceptor (D2A)" ⁇ -electronic system in which two acceptors are bound to one donor.
  • D2A donor-two-acceptor
  • QCy-DT is one of the classes belonging to the D2A fluorophore (QCy7).
  • the QCy-DT includes a donor phenol motif and two heterocyclic electron acceptors bonded to the donor phenol moiety.
  • QCy-DT has a curved molecular structure and can bind to the secondary groove of double-stranded DNA.
  • QCy-DT binds to double-stranded DNA, it undergoes internal charge transfer and is converted to a switch-on near-infrared fluorophore. That is, QCy-DT fluoresces when bound to double-stranded DNA.
  • QCy-DT is used as a fluorescent probe for the detection of double chain DNA.
  • Non-Patent Document 1 discloses QCy-DT as in Patent Document 1.
  • Non-Patent Document 2 discloses a "donor-2 acceptor (D2A)" dye.
  • Non-Patent Document 2 discloses various examples of potential acceptor moieties.
  • One aspect of the present disclosure is a method comprising the use of a compound for the detection of nucleic acids.
  • the compound used in the disclosed method has a structure represented by the general formula (1A) or the general formula (1B) described in the embodiment described later.
  • the disclosed compound has a structure represented by the general formula (1A) or the general formula (1B) described in the embodiment described later.
  • the disclosed fluorescent probes include the aforementioned compounds.
  • Another aspect of the present disclosure is a method comprising using the aforementioned compound for measuring the viscosity of a liquid.
  • the compound of the present disclosure may be a compound comprising a donor and three acceptors bound to the donor so as to rotate with respect to the donor, and the fluorescence changes according to a change in the rotational motion of each acceptor. ..
  • the method of the present disclosure comprises the use of a compound comprising a donor and three acceptors bound to the donor to rotate with respect to the donor and whose fluorescence changes in response to changes in the rotational motion of each acceptor. It may be a method including.
  • the use of the compound may be for the detection of nucleic acids or for the measurement of the viscosity of the liquid.
  • FIG. 1 is an explanatory diagram of a donor-3 acceptor structure and nucleic acid detection.
  • FIG. 2 is an explanatory diagram of a donor-2 acceptor structure and nucleic acid detection.
  • FIG. 3 is an explanatory diagram of the compound according to the embodiment.
  • FIG. 4 is an explanatory diagram of a method for producing a compound according to an embodiment.
  • FIG. 5 is a diagram showing the glycerol mixing ratio dependence of the fluorescence spectrum (excitation wavelength: 540 nm) of the compound (6 ⁇ M) according to the embodiment.
  • FIG. 6 is a diagram showing the correlation between the fluorescence intensity (680 nm) of the compound (6 ⁇ M) according to the embodiment and the mixing ratio of glycerol.
  • FIG. 5 is a diagram showing the glycerol mixing ratio dependence of the fluorescence spectrum (excitation wavelength: 540 nm) of the compound (6 ⁇ M) according to the embodiment.
  • FIG. 6 is a diagram showing the correlation between the flu
  • FIG. 7 is a diagram showing the correlation between the fluorescence intensity (680 nm) of the compound (6 ⁇ M) according to the embodiment and the solvent viscosity.
  • FIG. 8 is a diagram showing the dependence of the excitation spectrum (detection wavelength: 680) of the compound (6 ⁇ M) according to the embodiment on the glycerol mixture ratio.
  • FIG. 9 is a diagram in which the fluorescence intensity of FIG. 8 is normalized.
  • FIG. 10 is a diagram showing the correlation between the fluorescence intensity ratio (540 nm / 470 nm) of the compound according to the embodiment and the mixing ratio with glycerol.
  • FIG. 11 is a diagram showing the correlation between the fluorescence intensity ratio (540 nm / 470 nm) of the compound according to the embodiment and the solvent viscosity.
  • FIG. 12 is a diagram showing the glycerol mixing ratio dependence of the absorption spectrum of the compound (6 ⁇ M) according to the embodiment.
  • FIG. 13 is a diagram showing the correlation between the absorption maximum of the compound according to the embodiment and the mixing ratio of glycerol.
  • FIG. 14 is a diagram showing the correlation between the absorption maximum of the compound according to the embodiment and the solvent viscosity.
  • FIG. 17 is a diagram showing a 700 nm fluorescence intensity change when quadruplex DNA (Tel26, Tello_G4, MycG4) is added to the compound according to the embodiment.
  • FIG. 18 is a diagram showing a 700 nm fluorescence intensity change when double chain DNA (ds (A / T) 4 (T / A) 4 , ds (AAATTT)) is added to the compound according to the embodiment.
  • FIG. 19 is an image showing the results of staining fixed cells with the compound according to the embodiment.
  • FIG. 20 is a diagram showing the fluorescence intensity and the difference in intensity in the cells shown in FIG.
  • FIG. 21 is a diagram showing the relationship between the addition concentration of the compound according to the embodiment and the viable cell rate.
  • FIG. 22 is a diagram showing the results of staining of living cells (HeLa cells) with the compound according to the embodiment.
  • FIG. 23 is a diagram showing the fluorescence intensity and the difference in intensity in the cells shown in FIG. 22.
  • FIG. 24 is an image of fluorescence microscopic observation showing the response of live cells stained with the compound according to the embodiment to a quadruple chain stabilizing reagent (Pyridostatin (PDS)).
  • FIG. 25 is a dot plot quantifying the response (change in fluorescence intensity) of living cells (HeLa, A549, HEK2933, MRC-5) to PDS.
  • FIG. 26 is a photograph showing the presence or absence of precipitation depending on the type of solvent of the stain solution (probe solution).
  • FIG. 27 is an image showing the results of fluorescence microscopy observations (fixed cells) showing the results of a competitive experiment with Hoechist 33258.
  • FIG. 28 is an image showing the results of fluorescence microscopy observations (living cells) showing the results of a competitive experiment with Hoechist 33258.
  • the method according to the embodiment includes using a compound having a structure represented by the general formula (1A) or the general formula (1B) for detecting nucleic acid.
  • this compound is bound to a double-stranded nucleic acid or a quadruplex nucleic acid, its fluorescence characteristics change. Therefore, this compound is useful, for example, for the detection of nucleic acids.
  • RA , RB , and RC each have a structure independently selected from the group consisting of the following formulas (1C), formulas (1D), formulas (1E), and formulas (1F) (* indicates a combination).
  • X is selected from the group consisting of O, S, and Se.
  • R 1 , R 3 , R 5 , and R 7 are independently selected from the group consisting of H,-(CH 2 ) n-, and-(CH 2 CH 20 ) n-, where n. Is a natural number from 1 to 100, R2 , R4 , R6 , and R8 are independently H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, and sulfonate (SO 3- ) , aryl group. Or a derivative thereof, and a heterocyclic compound or a derivative thereof are selected from the group.
  • the method preferably comprises using the compound for the detection of at least one of a double-stranded nucleic acid and a quadruple-stranded nucleic acid.
  • the method preferably comprises using the compound for detecting a nucleic acid that distinguishes between a double-stranded nucleic acid and a quadruple-stranded nucleic acid.
  • the method preferably comprises using the compound for detecting the viscosity of a sample containing nucleic acid.
  • X is preferably S.
  • the compound according to the embodiment has a structure represented by the general formula (1A) or the general formula (1B).
  • this compound is bound to, for example, a double-stranded nucleic acid or a quadruplex nucleic acid, the rotational motion of the acceptor changes and the fluorescence characteristics change.
  • RA , RB , and RC each have a structure independently selected from the group consisting of the following formulas (1C), formulas (1D), formulas (1E), and formulas (1F) (* indicates a combination).
  • X is selected from the group consisting of O, S, and Se.
  • R 1 , R 3 , R 5 , and R 7 are independently selected from the group consisting of H,-(CH 2 ) n-, and-(CH 2 CH 20 ) n-, where n. Is a natural number from 1 to 100, R2 , R4 , R6 , and R8 are independently H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate ( SO 3- ) , aryl group or It is selected from the group consisting of the derivative and the heterocyclic compound or its derivative.
  • the fluorescent probe according to the embodiment preferably contains the compound described in (6) above.
  • the method according to the embodiment preferably comprises using the compound described in (6) above for measuring the viscosity of a liquid.
  • the fluorescence characteristics of the compound according to (6) change depending on the viscosity of the liquid. Therefore, the compound can be used for measuring the viscosity.
  • the compound according to the embodiment includes a donor and three acceptors bound to the donor so as to rotate with respect to the donor, and the fluorescence characteristics change according to changes in the rotational motion of each acceptor. May be.
  • the compound according to (9) above is preferably capable of binding to at least one of a double-stranded nucleic acid and a quadruple-stranded nucleic acid.
  • the compound according to (9) above is preferably capable of binding to both double-stranded nucleic acid and quadruplex nucleic acid.
  • the fluorescence intensity of the first wavelength is increased to the double chain.
  • the fluorescence intensity of the second wavelength which is different from the first wavelength, becomes larger than that at the time of non-binding to the nucleic acid. It is preferable that it becomes larger than.
  • the method according to the embodiment preferably comprises using the compound according to any one of (9) to (12) above for detecting nucleic acid.
  • the method according to the embodiment uses the compound according to any one of (9) to (12) above for detecting a nucleic acid that distinguishes between a double-stranded nucleic acid and a quadruple-stranded nucleic acid. It is preferable to include the above.
  • the method according to the embodiment preferably comprises using the compound according to any one of (9) to (12) above for measuring the viscosity of a liquid.
  • the rotational motion of the compound changes according to the viscosity of the liquid, and the fluorescence changes. Utilizing this, the compound can be used for measuring the viscosity.
  • FIG. 1 shows an outline of the compound 10 according to the embodiment and nucleic acid detection when the compound 10 is used as a fluorescent probe.
  • the compound according to the embodiment is suitable for detecting double-stranded nucleic acid and quadruple-stranded nucleic acid.
  • the compound 10 as a fluorescent probe is also suitable for measuring the viscosity.
  • Compound 10 has a "donor-three-acceptor (D3A)" structure comprising one donor 11 (donor site) and three acceptors 12A, 12B, 12C (acceptor sites).
  • FIG. 2 shows the structure of QCy-DT described in Patent Document 1 and Non-Patent Document 1 and the outline of nucleic acid detection when QCy-DT is used as a fluorescent probe.
  • QCy-DT is a compound 100 having a D2A structure comprising a donor phenol motif 111 and two heterocyclic electron acceptors 112A and 112B bonded to the donor phenol moiety 111.
  • Qcy-DT is a kind of quinone cyanine (QCy7) fluorescent probe (fluorescent dye).
  • the Qcy-DT is a two-legged type.
  • the "two-legged type" refers to a structure having two acceptors bound to one donor.
  • QCy7 quinone cyanine fluorescent dye is one of the classes of cyanine fluorescent probe (cyanine fluorescent dye).
  • cyanine fluorescent dye typically two heterocyclic electron acceptors are attached to the donor phenol moiety, and the heterocyclic electron acceptor in QCy7 is, for example, an alkylated quinolines, indolines, or. Pyridines.
  • QCy-DT is activated by deprotonation and functions as a near-infrared fluorescent probe.
  • the donor phenol moiety 111 becomes a phenolate.
  • Fenolate donates an electron to one of the two acceptors 112A and 112B (N-alkylated benzothiazole), and the internal charge to the nitrogen atom contained in the other acceptor of the two acceptors 112A and 112B. Trigger a move.
  • QCy-DT includes benzothiazole cations (benzothiazole groups) as acceptors 112A and 112B.
  • Each of the two acceptors 112A and 112B included in the QCy-DT can rotate (twist) with the coupling with the donor 111 as the axis of rotation.
  • the fluorescence characteristics of QCy-DT change. That is, the fluorescence characteristics of QCy-DT change according to the change in the rotational motion of the acceptors 112A and 112B.
  • the changing fluorescence property is, for example, at least one of the fluorescence wavelength and the fluorescence intensity.
  • the fluorescence is quenched or the intensity is reduced.
  • the rotation of the acceptors 112A and 112B is suppressed or stopped, the fluorescence intensity of a specific wavelength increases. That is, the QCy-DT quenches when the acceptors 112A and 112B are rotated, and emits fluorescence when the acceptors 112A and 112B stop rotating.
  • QCy-DT can bind to the accessory groove of double-stranded DNA. If the acceptors 112A and 112B of QCy-DT are not bound to the double-stranded DNA, the suppression of rotation is small and the fluorescence is quenched. However, as shown in FIG. 2, when the activated CQy-DT binds to the secondary groove of the double-stranded DNA, the rotation of the acceptors 112A and 112B is suppressed or stopped, and fluorescence of a specific wavelength (near infrared ray) is performed. ) Occurs. Therefore, QCy-DT can be used as a fluorescent probe.
  • QCy-DT has a D2A structure, and when two acceptors 112A and 112B bind to the sub-groove of the double-stranded nucleic acid, the rotation of the acceptors 112A and 112B is suppressed or stopped to emit fluorescence. Can be done. That is, QCy-DT fluoresces when bound to the sub-groove of the double-stranded nucleic acid, while the fluorescence becomes weaker at the time of non-binding than at the time of binding. Further, in QCy-DT, since charge transfer occurs between the two acceptors 112A and 112B whose rotation is suppressed or stopped, long-wavelength fluorescence can be emitted.
  • QCy-DT has sequence selectivity. That is, QCy-DT binds to AT-rich sequences in nucleic acids. More specifically, QCy-DT specifically binds to a double-stranded nucleic acid having the sequence of 5'-AAATTT-3'.
  • the bond is, for example, a hydrogen bond.
  • the compound 10 according to the embodiment is a three-legged type including the first acceptor 12A, the second acceptor 12B, and the third acceptor 12C bound to one donor 11.
  • the "three-legged type” refers to a structure having three acceptors bound to one donor.
  • the compound 10 according to the embodiment includes a donor 11 and three acceptors 12A, 12B, 12C bound to the donor 11 so as to rotate with respect to the donor 11, and changes in the rotational motion of each acceptor 12A, 12B, 12B.
  • the fluorescence characteristics change according to the above.
  • the compound 10 according to the embodiment can be considered to be an extension of the two-legged type CQy-DT to the three-legged type.
  • the donor 11 included in the compound 10 is composed of phenol, for example, like QCy-DT.
  • Each acceptor 12A, 12B, 12C included in compound 10 is composed of a benzothiazolium cation (benzothiazole group), for example, like QCy-DT.
  • Other examples of acceptors 12A, 12B, 12 will be described later.
  • the deprotonated donor phenol site 11 becomes a phenolate. Phenolates donate electrons to any of the three acceptors 12A, 12B, 12C.
  • Each of the acceptors 12A, 12B, and 12C included in the compound 10 according to the embodiment can rotate (twist) with the bond with the donor 11 as a rotation axis, similarly to the acceptors 112A, 112B included in the QCy-DT.
  • the binding with each acceptor 12A, 12B, 12C is, for example, a dimethin binding.
  • Compound 10 may be capable of binding to a secondary groove of a double-stranded nucleic acid (double-stranded DNA; dsDNA), similarly to QCy-DT. Focusing on two acceptors arbitrarily selected from the three acceptors 12A, 12B, 12C, compound 10 can have the same structure as QCy-DT, which is D2A. For example, in the compound 10 which is D3A, focusing on the donor 11, the first acceptor 12A, and the second acceptor 12B, the compound 10 can have the same structure as the QCy-DT which is D2A.
  • dsDNA double-stranded DNA
  • the compound 10 can have a structure similar to that of QCy-DT which is D2A. Further, paying attention to the donor 11, the third acceptor 12C, and the first acceptor 12A, the compound 10 can have a structure similar to that of QCy-DT which is D2A.
  • compound 10 can be bound to the sub-groove of a double-stranded nucleic acid such as double-stranded DNA by two acceptors arbitrarily selected from the three acceptors 12A, 12B, and 12C, similar to QCy-DT. You may.
  • the pair of the first acceptor 12A and the second acceptor 12B in compound 10 can bind to the secondary groove of the double-stranded DNA.
  • the rotation of the first acceptor 12A and the second acceptor 12B coupled to the sub-groove is suppressed or stopped.
  • fluorescence near infrared rays
  • the third acceptor 12C that is not coupled to the secondary groove is rotatable.
  • the pair of the second acceptor 12B and the third acceptor 12C in the compound 10 can bind to the sub-groove of the double-stranded DNA.
  • the rotation of the second acceptor 12B and the third acceptor 12C coupled to the sub-groove is suppressed or stopped.
  • fluorescence near infrared rays
  • the first acceptor 12A that is not coupled to the secondary groove is rotatable.
  • the pair of the third acceptor 12C and the first acceptor 12A in the compound 10 can bind to the sub-groove of the double-stranded DNA.
  • the rotation of the third acceptor 12C and the first acceptor 12A coupled to the sub-groove is suppressed or stopped.
  • fluorescence near infrared rays
  • the second acceptor 12B that is not coupled to the secondary groove is rotatable.
  • the three-legged compound 10 has the same fluorescence characteristics as the QCy-DT, in which the fluorescence characteristics change according to the change in the rotational motion of the acceptors 12A, 12B, and 12C. Therefore, compound 10 can preferably be used as a fluorescent probe (fluorescent dye) for detecting double-stranded nucleic acids. That is, the compound 10 may emit fluorescence when bound to the sub-groove of the double-stranded nucleic acid, while the fluorescence intensity may be lower at the time of non-binding than at the time of binding. In addition, also in compound 10, since charge transfer occurs between acceptors whose rotation is stopped or suppressed, compound 10 can emit fluorescence having a long wavelength.
  • the compound 10 may have sequence selectivity as in the case of QCy-DT. That is, compound 10 may bind to an AT-rich sequence in nucleic acid. More specifically, compound 10 may specifically bind to a double-stranded nucleic acid having the sequence of 5'-AAATTT-3'.
  • the three-legged compound 10 can bind not only to double-stranded nucleic acids but also to quadruplex nucleic acids. Since the three-legged compound 10 includes the three acceptors 12A, 12B, and 12C, the molecular structure is generally flat as compared with the two-legged compound 100. By being planar, the compound 10 can bind to the G4 plane (G-Quartet) of the quadruplex nucleic acid.
  • G-Quartet G4 plane
  • the quadruplex nucleic acid is also referred to as a guanine quadruplex (G-Quadruplex: G4).
  • the guanine quadruple chain is formed by guanine-rich DNA or RNA.
  • the guanine quadruplex is a structure in which a planar structure (G4 planar) formed by four guanine bases and called G-Quartet is stacked.
  • the structure of the guanine quadruple chain (G4) may be any of a parallel type, an antiparallel type, and a hybrid type. In any structure, the guanine quadruple has a G4 plane formed by four guanine bases.
  • the compound 10 Since the compound 10 has a planar shape, it has a property of easily binding to a G4 plane (G-Quartet) which is also a flat surface. That is, the planar compound 10 can be bonded so as to be planarly overlapped on the G4 plane.
  • the binding between the compound 10 and the quadruple-stranded nucleic acid may be a hydrophobic bond or a stacking due to a binding force generated between planes due to a ⁇ - ⁇ stacking interaction.
  • the three-legged compound 10 can be used as a fluorescent probe (fluorescent dye) for detecting a quadruple-stranded nucleic acid. That is, compound 10 fluoresces when bound to a quadruple-stranded nucleic acid, while its fluorescence intensity is lower when it is not bound than when it is bound.
  • fluorescence near infrared rays
  • the wavelength at which the fluorescence intensity increases when the compound 10 binds to the double-stranded nucleic acid is different from the wavelength at which the fluorescence intensity increases when the compound 10 binds to the double-stranded nucleic acid.
  • nucleic acid when nucleic acid is detected using compound 10, whether the detected nucleic acid is a double-stranded nucleic acid or a quadruple-stranded nucleic acid is determined by the fluorescence color (wavelength of fluorescence) whose intensity increases from the compound 10. Can be distinguished.
  • compound 10 fluoresces when the rotation of some or all of the three acceptors 12A, 12B, 12C is suppressed or stopped.
  • the generation of fluorescence is not limited to the binding of double-stranded nucleic acid or quadruplex nucleic acid, but also occurs when the rotation of some or all of the three acceptors 12A, 12B, 12C is suppressed or stopped due to other factors.
  • Another factor is, for example, the viscosity of the liquid in which compound 10 is present. When the viscosity is high, the rotation of the acceptors 12A, 12B, 12C is suppressed.
  • Compound 10 is represented by, for example, the above-mentioned general formula (1A) or general formula (1B).
  • Compound 10 is a three-legged type (D3A) and is used as a novel quinone cyanine fluorescent probe (quinone cyanine fluorescent dye).
  • the compound 10 represented by the general formula (1A) has phenol as the donor 11 (donor site), and the phenol has three acceptors (acceptor sites: RA and RB in the general formulas (1A) and (1B)). , RC ) are combined.
  • the compound 10 represented by the general formula (1B) is a deprotonated compound 10 represented by the general formula (1A) (activated compound 10), and the phenol in the general formula (1A) is phenolate. It has changed to.
  • the activated compound 10 functions as a near-infrared fluorescent probe.
  • the RA , RB, and RC (acceptors) in the general formulas (1A) and (1B) are independently derived from the above - mentioned formulas (1C), (1D), formula (1E), and formula (1F), respectively. It has a structure selected from the group consisting of.
  • RA , RB , RC may all have a structure represented by the formula (1C), all may have a structure represented by the formula (1D), and all may have a structure represented by the formula (1D). It may have the structure represented by (1E), or all may have the structure represented by the formula (1F).
  • RA , RB , and RC in the general formulas (1A) and (1B) may all have different structures.
  • the structure represented by the formula (1D) is planar as compared with the structure represented by the formula (1C), and is advantageous for binding to a quadruplex nucleic acid.
  • the structure represented by the formula (1E) is planar as compared with the structure represented by the formula (1C), and is advantageous for binding to a quadruplex nucleic acid.
  • the structure represented by the formula (1F) is planar as compared with the structure represented by the formula (1D), and is advantageous for binding to a quadruplex nucleic acid.
  • RA has the structure represented by the formula (1C)
  • RB has the structure represented by the formula (1C)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has a structure represented by the formula (1C)
  • RB has a structure represented by the formula (1D)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1C)
  • RB has the structure represented by the formula (1E)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has a structure represented by the formula (1C)
  • RB has a structure represented by the formula (1F)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has a structure represented by the formula (1D)
  • RB has a structure represented by the formula (1C)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1D)
  • RB has the structure represented by the formula (1D)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1D)
  • RB has the structure represented by the formula (1E)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1D)
  • RB has the structure represented by the formula (1F)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1E)
  • RB has the structure represented by the formula (1C)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1E)
  • RB has the structure represented by the formula (1D)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula ( 1E )
  • RB has the structure represented by the formula (1E)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1E)
  • RB has the structure represented by the formula (1F)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has a structure represented by the formula (1F)
  • RB has a structure represented by the formula (1C)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has a structure represented by the formula (1F)
  • RB has a structure represented by the formula (1D)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has the structure represented by the formula (1F)
  • RB has the structure represented by the formula (1E)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • RA has a structure represented by the formula (1F)
  • RB has a structure represented by the formula (1F)
  • RC has the formula (1C), the formula (1D), the formula (1E) and the formula. It may have a structure selected from the group consisting of (1F).
  • Patent Document 1 An example of a general acceptor is described in Patent Document 1 which discloses QCy-DT. Therefore, as the acceptor included in the compound 10, the same acceptor as that described in Patent Document 1 can be adopted.
  • Non-Patent Document 1 and Non-Patent Document 2 may be referred to.
  • X is preferably selected from the group consisting of O, S, and Se as in Patent Document 1. Since X is any element selected from the group consisting of O, S, and Se, each acceptor becomes rotatable. X is more preferably S.
  • R 1 in the formula (1D), (1D), (1E) or (1E) is preferably H or ⁇ (CH 2 ) n ⁇ . Further, R 1 may be ⁇ (CH 2 CH 20 ) n ⁇ . That is, R 1 is preferably selected from the group consisting of H,-( CH2 ) n-, and-( CH2 CH20) n-. Here, n is a natural number from 1 to 100. The rotation speed of the acceptor can be controlled by changing n.
  • R 3 is preferably H or ⁇ (CH 2 ) n ⁇ . Further, R 3 may be ⁇ (CH 2 CH 20 ) n ⁇ . That is, R 3 is preferably selected from the group consisting of H,-( CH2 ) n-, and-( CH2 CH20) n-. Here, n is a natural number from 1 to 100. The rotation speed of the acceptor can be controlled by changing n.
  • R 5 is preferably H or ⁇ (CH 2 ) n ⁇ . Further, R 5 may be ⁇ (CH 2 CH 20 ) n ⁇ . That is, R 5 is preferably selected from the group consisting of H,-( CH2 ) n-, and-( CH2 CH20) n-. Here, n is a natural number from 1 to 100. The rotation speed of the acceptor can be controlled by changing n.
  • R 7 is preferably H or ⁇ (CH 2 ) n ⁇ .
  • R 5 may be ⁇ (CH 2 CH 20 ) n ⁇ . That is, R 5 is preferably selected from the group consisting of H,-( CH2 ) n-, and-( CH2 CH20) n-.
  • n is a natural number from 1 to 100.
  • the rotation speed of the acceptor can be controlled by changing n.
  • -R 1 -R 2 is-(CH 2 ) n-H, oligoethylene glycol chain (-(CH 2 CH 20 ) n-H), or (-(CH 2 CH 20 ) n-CH 3 ). ), In which case compound 10 is suitable as a viscosity probe for viscosity measurement.
  • ⁇ R 1 ⁇ R 2 is ⁇ (CH 2 ) n—H
  • n is preferably a natural number from 1 to 18.
  • -R 1 -R 2 is-(CH 2 CH 20 ) n-H or-(CH 2 CH 20 ) n-CH 3
  • n is a natural number from 1 to 100. It is preferable that the natural number is 1 to 36, more preferably 1 to 6, and even more preferably 1 to 6.
  • -R 3 -R 4 is-(CH 2) n-H, oligoethylene glycol chain (-(CH 2 CH 20 ) n-H), or (-(CH 2 CH 20 ) n-CH 3 ).
  • compound 10 is suitable as a viscosity probe for measuring viscosity.
  • ⁇ R 3 ⁇ R 4 is ⁇ (CH 2 ) n—H
  • n is preferably a natural number from 1 to 18.
  • -R 3 -R 4 is-(CH 2 CH 20 ) n-H or-(CH 2 CH 20 ) n-CH 3
  • n is a natural number from 1 to 100. It is preferable that the natural number is 1 to 36, more preferably 1 to 6, and even more preferably 1 to 6.
  • -R 5 -R 6 is-(CH 2 ) n-H, oligoethylene glycol chain (-(CH 2 CH 20 ) n-H), or (-(CH 2 CH 2 0) n-CH 3 ). ), In which case compound 10 is suitable as a viscosity probe for viscosity measurement.
  • ⁇ R5 ⁇ R6 is ⁇ (CH 2 ) n—H
  • n is preferably a natural number from 1 to 18.
  • -R 5 -R 6 is-(CH 2 CH 20 ) n-H or-(CH 2 CH 20 ) n-CH 3
  • n is a natural number from 1 to 100. It is preferable that the natural number is 1 to 36, more preferably 1 to 6, and even more preferably 1 to 6.
  • -R 7 -R 8 is-(CH 2 ) n-H, oligoethylene glycol chain (-(CH 2 CH 20 ) n-H), or (-(CH 2 CH 2 0) n-CH 3 ). ), In which case compound 10 is suitable as a viscosity probe for viscosity measurement.
  • ⁇ R 7 ⁇ R 8 is ⁇ (CH 2 ) n—H
  • n is preferably a natural number from 1 to 18.
  • -R 7 -R 8 is-(CH 2 CH 20 ) n-H or-(CH 2 CH 20 ) n-CH 3
  • n is a natural number from 1 to 100. It is preferable that the natural number is 1 to 36, more preferably 1 to 6, and even more preferably 1 to 6.
  • R2 is also selected from the group consisting of H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, and sulfonate (SO 3- ) . preferable.
  • R 2 may be an aryl group such as phenyl (C 6 H 5 ), naphthyl, or pyrene, or a derivative thereof.
  • R2 may be a heterocyclic compound such as thiophene, pyridyl, furan, imidazole, triazole, carbazole, coumarin or a derivative thereof.
  • R 2 is H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate (SO 3- ) , aryl group or derivative thereof, and heterocyclic compound or derivative thereof. It is preferably selected from the group consisting of.
  • R4 may also be an aryl group such as phenyl (C 6 H 5 ), naphthyl, or pyrene or a derivative thereof.
  • R4 may be a heterocyclic compound such as thiophene, pyridyl, furan, imidazole, triazole, carbazole, coumarin or a derivative thereof. That is, R4 is H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate (SO 3- ) , aryl group or derivative thereof, and heterocyclic compound or derivative thereof. It is preferably selected from the group consisting of.
  • R 6 may also be an aryl group such as phenyl (C 6 H 5 ), naphthyl, or pyrene, or a derivative thereof.
  • R6 may be a heterocyclic compound such as thiophene, pyridyl, furan, imidazole, triazole, carbazole, coumarin or a derivative thereof. That is, R 6 is H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate (SO 3- ) , aryl group or derivative thereof, and heterocyclic compound or derivative thereof. It is preferably selected from the group consisting of.
  • R 8 may also be an aryl group such as phenyl (C 6 H 5 ), naphthyl, or pyrene, or a derivative thereof.
  • R4 may be a heterocyclic compound such as thiophene, pyridyl, furan, imidazole, triazole, carbazole, coumarin or a derivative thereof. That is, R4 is H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate (SO 3- ) , aryl group or derivative thereof, and heterocyclic compound or derivative thereof. It is preferably selected from the group consisting of.
  • the compound 10 represented by the general formula (1A) is preferably the compound 10 represented by the following general formula (2A).
  • the compound 10 represented by the general formula (2A) adopts the structure represented by the general formula (1C) as RA , RB , and RC in the general formula (1A).
  • the compound 10 represented by the general formula (1B) is preferably the compound 10 represented by the following general formula (2B).
  • the compound 10 represented by the general formula (2B) adopts the structure represented by the general formula (1C) as RA , RB , and RC in the general formula (1B).
  • Compound 10 represented by the general formulas (2A) and (2B) comprises a donor and three acceptors bound to the donor so as to rotate with respect to the donor, and the fluorescence characteristics are changed according to the change of the rotational motion of each acceptor. Changes.
  • X A , X B , and X C are preferably independently selected from the group consisting of O, S, and Se, respectively. It is preferable that X A , X B , and X C are S independently of each other. X A , X B , and X C may all be S.
  • R 1A , R 1B , and R 1C are independently similar to the above-mentioned R 1 . That is, it is preferable that R 1A , R 1B , and R 1C are independently selected from the group consisting of H,-(CH 2 ) n-, and-(CH 2 CH 20 ) n-.
  • n is a natural number from 1 to 100.
  • R 1A , R 1B , and R 1C may all be the same.
  • R 2A , R 2B , and R 2C are independently similar to the above-mentioned R 2 . That is, R 2A , R 2B , and R 2C are independently H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate (SO 3- ) , aryl group or the like. It is preferably selected from the group consisting of derivatives and heterocyclic compounds or derivatives thereof. R 2A , R 2B , and R 2C may all be the same.
  • -R 1A -R 2A , -R 1B -R 2B , -R 1C -R 2C are independently- (CH 2 ) n-H, oligoethylene glycol chain (-(CH 2 CH 20 ) n. -H) or (-(CH 2 CH 20 ) n-CH 3 ) may be used.
  • Compound 10 represented by the general formulas (2A) and (2B) is suitable for detecting at least one of a double-stranded nucleic acid and a quadruple-stranded nucleic acid.
  • the acceptor sites 12A, 12B and 12C of the compound 10 resemble the structure of the acceptor site of QCy-DT.
  • the acceptor sites 12A, 12B, 12C of compound 10 may have low similarity to the structure of the acceptor site of QCy-DT. ..
  • the binding performance to the double-stranded nucleic acid may be deteriorated, but the stacking interaction is increased due to the expansion of the planar structure.
  • the binding performance to the quadruplex nucleic acid is improved.
  • compound 10 is suitable as a quadruplex nucleic acid-selective fluorescent probe.
  • R 2A , R 2B , and R 2C contained in the three acceptors of compound 10 are H and the remaining one is a functional group having high planarity, 2 contained in compound 10.
  • the QCy-DT structure is maintained between the acceptor and the donor.
  • the double-stranded nucleic acid and the quadruple-stranded nucleic acid can be detected by fluorescence having different wavelengths.
  • the compound 10 represented by the general formula (2A) is preferably the compound 10 represented by the following general formula (2C).
  • Compound 10 represented by the general formula (2C) contains three benzothiazolium cations centered on phenol via a dimethine bond.
  • R 1A , R 1B , and R 1C in the general formula (2A) are CH 2
  • R 2A , R 2B , and R 2C are H.
  • the compound 10 represented by the general formula (2B) is preferably the compound 10 represented by the following general formula (2D).
  • R 1 in the general formula (2B) is CH 2 and R 2 is H.
  • X A , X B , and X C are preferably independently selected from the group consisting of O, S, and Se, respectively. It is preferable that X A , X B , and X C are S independently of each other. X A , X B , and X C may all be S.
  • the compound 10 in which X A , X B , and X C in the general formula (2C) are all S may be referred to as “QCy (BT) 3 ”. Further, the compound 10 in which X A , X B , and X C in the general formula (2D) are all S may be referred to as “activated QCy (BT) 3 ”.
  • the compound 10 represented by the general formula (2D) is a deprotonated compound 10 represented by the general formula (2C) (activated compound 10).
  • the compound 10 represented by the general formula (1A) is preferably the compound 10 represented by the following general formula (3A).
  • the compound 10 represented by the general formula (3A) adopts the structure represented by the general formula (1D) as RA , RB , and RC in the general formula (1A).
  • the compound 10 represented by the general formula (3A) is more planar than the compound 10 represented by the general formula (2A), and is advantageous for binding to a quadruplex nucleic acid.
  • the compound 10 represented by the general formula (1B) is preferably the compound 10 represented by the following general formula (3B).
  • the compound 10 represented by the general formula (3B) adopts the structure represented by the general formula (1D) as RA , RB , and RC in the general formula (1B).
  • the compound 10 represented by the general formula (3B) is more planar than the compound 10 represented by the general formula (2B), and is advantageous for binding to a quadruplex nucleic acid.
  • the compound 10 represented by the general formulas (3A) and (3B) was bound to the donor and the donor so as to rotate with respect to the donor, similarly to the compound 10 represented by the general formulas (2A) and (2B). It is equipped with two acceptors, and the fluorescence characteristics change according to changes in the rotational motion of each acceptor.
  • X A , X B , and X C are preferably independently selected from the group consisting of O, S, and Se, respectively. It is preferable that X A , X B , and X C are S independently of each other. X A , X B , and X C may all be S.
  • R 3A , R 3B , and R 3C are independently similar to the above-mentioned R 1 or R 3 . That is, it is preferable that R 3A , R 3B , and R 3C are independently selected from the group consisting of H,-( CH2 ) n-, and-( CH2 CH20) n-. Here, n is a natural number from 1 to 100. R 3A , R 3B , and R 3C may all be the same.
  • R 4A , R 4B , and R 4C are independently similar to the above-mentioned R 2 or R 4 . That is, R 4A , R 4B , and R 4C are independently H, -OH, methyl, amine, terminal alkyne, alkene, alkyl acid, amine acid, sulfonate (SO 3- ) , aryl group or its own. It is preferably selected from the group consisting of derivatives and heterocyclic compounds or derivatives thereof. R 4A , R 4B , and R 4C may all be the same.
  • -R 3A -R 4A , -R 3B -R 4B , -R 3C -R 4C are independent of-(CH 2 ) n-H, oligoethylene glycol chain (-(CH 2 CH 20 ) n. -H) or (-(CH 2 CH 20 ) n-CH 3 ) may be used.
  • R 3A , R 3B , and R 3C in the general formula (3A) or (3B) are CH 2 , and R 4A , R 4B , and R 4C are H.
  • the compound 10 represented by the general formula (3B) is a deprotonated compound 10 represented by the general formula (3A) (activated compound 10).
  • Compound 10 represented by the general formulas (3A) and (3B) is also suitable for detecting at least one of a double-stranded nucleic acid and a quadruple-stranded nucleic acid.
  • the compound 10 represented by the general formulas (3A) and (3B) has a large planarity and is therefore advantageous for binding to a quadruplex nucleic acid.
  • FIG. 4 shows a method for producing activated QCy (DT) 3 (compound 10 in which X A , X B , and X C are all S in the formula (2D)).
  • DT activated QCy
  • 2,3-dimethylbenzothiazolium iodide (50 mg, 172 ⁇ mol) and 2-hydroxy-1,3,5-benzenetricarboxyaldehyde (9 mg, 5 ⁇ mol) were added to ethanol (5 mL) in ethanol (5 mL). After stirring at 95 ° C. for 10 minutes, aniline (14 ⁇ L, 152 mmol) was added.
  • 2,3-Dimethylbenzothiazolium iodide is the starting material (precursor) corresponding to acceptor sites 12A, 12B, 12C, and 2-hydroxy-1,3,5-benzenetricarboxyaldehyde is at donor site 11.
  • the counter anion in 2,3-dimethylbenzothiazolium iodide is not limited to I ⁇ , but may be Cl ⁇ , Br ⁇ or tosyl anion.
  • the obtained compound 10 was a deep purple solid.
  • the amount of the obtained compound 10 was 8.3 mg and 9.9 ⁇ mol, and the yield was 20%.
  • the obtained compound 10 corresponds to a compound in which X A , X B , and X C in the formula (2D) are all S.
  • the tripod type corresponds to, for example, 2-hydroxy-1,3,5-benzenetricarboxyaldehyde described above. It is preferable to use a substance having three aldehyde groups (-CHO) as a starting material (starting material (precursor) corresponding to the donor site). When the starting material has two aldehyde groups, it becomes a two-legged type (D2A) like QCy-DT.
  • the method for producing the compound 10 is based on the method for producing a two-legged (D2A) compound (QCy-DT, etc.), but as a starting material corresponding to the donor site, 3 A substance suitable for the one-legged type may be used.
  • the starting material (precursor) corresponding to the acceptor site is not limited to 2,3-dimethylbenzothiazolium iodide.
  • a molecule having an active methylene group (corresponding to the methyl group at the 2-position of 2,3-dimethylbenzothiazolium iodide) has an olefin structure (double bond) by condensing with an aldehyde by Knephener gel condensation. Can be made. The above-mentioned manufacturing method utilizes this.
  • 2-methyl-3- (R 1 R 2 ) -benzothiazolium iodide (the counter anion is not limited to I-, Cl- , Br- or Tosyl anion may be used) or 4,5-diphenyl-2-methyl-3- (R 1 R 2 ) -thiazolium iodide (the counter anion is not limited to I-, but Cl- , Br- or tosyl anion. Good) may be used.
  • the three-legged (D3A) structure according to the embodiment can be obtained by Knephener gel condensation with 2-hydroxy-1,3,5-benzenetricarboxyaldehyde, as in the above-mentioned production method.
  • 2,3-dimethylbenzothiazolium iodide can be synthesized by reacting methyl iodide (CH 3 I) with 2-methylbenzothiazole as a raw material.
  • 2-Methyl-3- (R 1 R 2 ) -benzothiazolium iodide (or bromide) is made from 2-methylbenzothiazole and has the general formula R 2 CH 2 I (or R 2 CH 2 Br). It can be synthesized by reacting with the represented compound.
  • the molecule that becomes the element of the acceptor may be one kind or two kinds. There may be three types.
  • compound 10 can be produced by adding 3 mol equivalents or more of a mixture of two or more kinds of molecules (precursors of acceptors) that are elements of acceptors to trialdehyde as a donor and reacting them.
  • the product is a mixture of compounds 10 with different structures.
  • the desired molecule is placed at the desired position in the compound 10. Can be combined.
  • FIG. 5 shows the measurement results of the fluorescence spectrum (excitation wavelength: 540 nm) in the first experiment.
  • the vertical axis of FIG. 5 indicates the fluorescence intensity, and the horizontal axis indicates the wavelength.
  • FIG. 5 shows the fluorescence intensities of each of the 11 types of solvents.
  • the fluorescence intensity (wavelength: 680 nm) was increased by increasing the viscosity of the solvent in which the compound 10 was dissolved.
  • the viscosity of the solvent in which the compound 10 is present is high, the rotation of the acceptors 12A, 12B, and 12C is suppressed or stopped, and the fluorescence intensity becomes high. The higher the viscosity, the higher the fluorescence intensity.
  • the fluorescence intensity increased at a wavelength of 680 nm.
  • the rotation of the acceptors 12A, 12B, and 12C is not suppressed, so that the fluorescence intensity gradually decreases, and when the viscosity becomes sufficiently low, the fluorescence is quenched.
  • FIG. 6 and 7 show the correlation between the fluorescence intensity and the solvent viscosity.
  • the vertical axis shows the fluorescence intensity at 680 nm
  • the horizontal axis shows the mixing ratio of glycerol.
  • the horizontal axis of FIG. 6 is represented by the viscosity (logarithm) of the solvent.
  • the fluorescence intensity changes linearly with respect to the logarithm of the solvent viscosity. Therefore, when compound 10 is used, it is possible to measure the viscosity (solvent viscosity) of the liquid in which compound 10 is present, using the fluorescence intensity of a specific wavelength (for example, 680 nm) emitted by compound 10 as an index.
  • FIG. 8 and 9 show the measurement results of the excitation spectrum (detection wavelength 680 nm) in the first experiment.
  • the vertical axis of FIG. 8 indicates the fluorescence intensity, and the horizontal axis indicates the wavelength.
  • FIG. 9 shows that the fluorescence intensity is normalized so that the maximum value of the fluorescence intensity for each viscosity shown in FIG. 8 becomes 1.
  • the maximum excitation wavelength shifts to a longer wavelength.
  • the maximum excitation wavelength was 470 nm
  • the maximum excitation wavelength was 540 nm
  • FIG. 10 and 11 show the correlation between the fluorescence intensity ratio and the solvent viscosity.
  • the vertical axis shows the fluorescence intensity ratio (I680 (ex540) / I680 (ex470)), and the horizontal axis shows the mixing ratio of glycerol.
  • the horizontal axis of FIG. 10 is represented by the viscosity (logarithm) of the solvent.
  • the fluorescence intensity ratio changes linearly with respect to the logarithm of the solvent viscosity (cP). Therefore, when compound 10 is used, it is possible to measure the viscosity (solvent viscosity) of the liquid in which the compound 10 is present, using the fluorescence intensity ratio as an index.
  • FIG. 12 shows the results of measuring the absorption spectra of each solvent containing the compound 10.
  • the vertical axis represents the absorbance and the horizontal axis represents the wavelength.
  • FIG. 13 shows the result of measuring the absorption spectrum in relation to the absorption maximum wavelength and the mixing ratio (viscosity) of glycerol.
  • the vertical axis indicates the absorption maximum wavelength
  • the horizontal axis indicates the mixing ratio (viscosity) of glycerol.
  • the viscosity solvent viscosity
  • the absorption maximum wavelength shifts to a longer wavelength. Therefore, when compound 10 is used, it is possible to measure the viscosity (solvent viscosity) of the liquid in which the compound 10 is present, using the absorption maximum wavelength of the solvent as an index.
  • the fluorescence of compound 10 changes according to the viscosity of the liquid in which the compound 10 is present. Therefore, when compound 10 is used, the viscosity of the liquid in which compound 10 is present can be measured. In the viscosity measurement using the compound 10, it is preferable that at least one of the fluorescence intensity, the fluorescence wavelength, the fluorescence intensity ratio, and the absorbance, which changes depending on the viscosity, is measured as an index for determining the viscosity.
  • the viscosity can be measured if the three acceptor sites can rotate.
  • the rotation speed By controlling the rotation speed by the difference in the functional groups introduced into R 1 or R 3 , it is possible to control the range of viscosity change that can be measured with high accuracy. For example, when ⁇ (CH 2 CH 20 ) n ⁇ is introduced as R 1 or R 3 , the rotation speed can be controlled by changing the value of n.
  • a sample was prepared by adding nucleic acid (6 ⁇ M) to compound 10 (6 ⁇ M) synthesized as shown in “2.3 Method for producing compound” and FIG.
  • a first sample was obtained by adding double-stranded DNA (ds (AAATTT)) containing an AAAATTT sequence to compound 10.
  • the second sample was obtained by adding double-stranded DNA (ds (AAGCTT)) containing no AAAATTT sequence to compound 10.
  • the third sample was obtained by adding a quadruple DNA (Telo_G4) containing a telomere sequence.
  • the compound 10 to which no nucleic acid was added was used as the fourth sample.
  • Each sample contains 50 mM Tris-HCl buffer (Tris-HCl) and 100 mM potassium chloride (KCL).
  • FIG. 15 shows the measurement result.
  • the vertical axis of FIG. 15 indicates the fluorescence intensity, and the horizontal axis indicates the wavelength.
  • FIG. 16 shows the results of measuring the fluorescence spectra of the first sample, the second sample, the third sample, and the fourth sample by changing the excitation wavelength to 570 nm.
  • compound 10 as a fluorescent probe (fluorescent dye)
  • double-stranded nucleic acid can be detected in the same manner as QCy-DT.
  • Compound 10 can specifically bind to a double-stranded nucleic acid having an AAAATTT sequence, similar to QCy-DT.
  • compound 10 as a fluorescent probe (fluorescent dye)
  • quadruplex nucleic acid can be detected.
  • the wavelength at which the fluorescence intensity increases when bound to a double-stranded nucleic acid and the wavelength at which the fluorescence intensity increases when bound to a quadruple-stranded nucleic acid are different. Therefore, it is possible to determine whether the DNA structure contained in the sample is a double-stranded nucleic acid or a quadruple-stranded nucleic acid from the difference in fluorescence wavelength.
  • the compound 10 can also be used for viscosity measurement as described above. Therefore, it is possible to detect nucleic acid and measure the viscosity of the environment in which the nucleic acid is present at the same time. For example, when compound 10 is bound to a quadruple-stranded nucleic acid, at least one of fluorescence intensity, fluorescence wavelength, fluorescence intensity ratio, and absorbance depends on the magnitude of the viscosity of the environment in which the quadruple-stranded nucleic acid is present. Change.
  • the DNA structure contained in the sample is a double-stranded nucleic acid or a quadruple-stranded nucleic acid, and the nucleic acid is the double-stranded nucleic acid.
  • the viscosity of the existing environment can be determined.
  • I included in the vertical axis is the fluorescence intensity
  • I0 included in the vertical axis is the fluorescence intensity when the quadruple-stranded nucleic acid or the double-stranded nucleic acid is not added.
  • the horizontal axis is the concentration ratio of the compound 10 to the quadruple-stranded nucleic acid or the double-stranded nucleic acid.
  • compound 10 is described as QCy (MeBT) 3 .
  • the dissociation constants of compound 10 and Tel26 are 1.6 ⁇ 10-7 M
  • the dissociation constants of compound 10 and Tello_G4 are 1. It was .6 ⁇ 10 -7 M
  • the dissociation constants of compound 10 and MycG4 were 0.9 ⁇ 10 -7 M. The smaller the dissociation constant, the greater the bond strength.
  • compound 10 has a binding affinity equal to or higher than that of the conventional quadruplex nucleic acid ligand. That is, the dissociation constants of the conventional quadruplex nucleic acid ligand and quadruplex nucleic acid are about 1.0 to 10 ⁇ 10-6 . Since the dissociation constant between the compound 10 and the quadruple-stranded nucleic acid is about 0.9 to 1.6 ⁇ 10-7 , the compound 10 has a binding affinity equal to or higher than that of the conventional quadruplex nucleic acid ligand. ..
  • the dissociation constants of the compound 10 and ds (A / T) 4 (T / A) 4 are 1.3 ⁇ 10-7 .
  • the dissociation constants of compound 10 and ds (AAATTT) were 1.1 ⁇ 10-7 .
  • the compound 10 has a higher binding strength to the double-stranded nucleic acid than the conventional fluorescent ds probe QCy-DT. That is, since the dissociation constants of QCy-DT and double-stranded nucleic acid (ds (AAATTT)) are about 6.7 ⁇ 10-7 , which are relatively large, the binding affinity of QCy-DT is relatively small. However, since the dissociation constants of the compound 10 and the double-stranded nucleic acid are relatively small, about 1.1 to 1.3 ⁇ 10-7 , the binding affinity of the compound 10 is relatively large.
  • Compound 10 is advantageous as a fluorescent probe for nucleic acid because it has a relatively high binding affinity with nucleic acid. Since the compound 10 has three positively charged legs, it is considered that the binding force to the negatively charged nucleic acid is increased.
  • the quadruplex nucleic acid and the double-stranded nucleic acid in the fixed cell were stained using "2.3 Method for producing a compound" and the compound 10 synthesized as shown in FIG.
  • HeLa cells cultured in a single layer were fixed and washed with phosphate buffered saline (PBS). Immobilization was performed by immersing HeLa cells in a 25% (V / V) acetic acid / methanol solution at room temperature for 10 minutes.
  • FIG. 19 shows the results of the fourth experiment.
  • "A” is a phase difference observation image (Ph) of cells.
  • the fluorescent image of "B” shows that the double chain DNA present in the cell nucleus of the cell shown in “A” is stained with 600 nm fluorescence.
  • the fluorescent image of "C” shows that the quadruplex DNA and quadruple RNA present in the cell nucleus of the cell shown in “A” are stained with 700 nm fluorescence.
  • the compound 10 can be used to stain both the quadruplex nucleic acid and the double-stranded nucleic acid in the fixed cell simultaneously and with different color fluorescence.
  • “D” in FIG. 19 is a superposition of "B” and “C”
  • "E” is an enlarged image of "D”.
  • FIG. 20 shows the intensity and intensity difference ( ⁇ int.) Of 700 nm fluorescence and 600 nm fluorescence in three cells (F-1, G-1, H-1) arbitrarily picked up from “E” in FIG. ) Is shown.
  • F-2, G-2, and H-2 of FIG. 20 the Position on the horizontal axis indicates the position along the white line with respect to the position S of F-1, G-1, and H-1.
  • the difference in intensity (Intensity) and the difference in intensity ( ⁇ int.) Of 700 nm fluorescence and 600 nm fluorescence correspond to the amounts of the quadruplex nucleic acid and the double-stranded nucleic acid in the cell. Therefore, it is possible to identify the location where a large amount of quadruplex nucleic acid is present based on the intensity of each of the 700 nm fluorescence and the 600 nm fluorescence.
  • the cytotoxicity of the compound 10 synthesized as shown in "2.3 Method for producing the compound” and FIG. 4 was evaluated.
  • a 5% aqueous glucose solution of compound 10 (0 ⁇ M, 0.5 ⁇ M, 1 ⁇ M, 2.5 ⁇ M, 5 ⁇ M) was used for each of the monolayer-cultured HeLa cells, A549 cells, HEK293 cells, and MRC-5 cells.
  • the viable cell rate was measured using a commercially available cell number ratio color measurement kit.
  • FIG. 21 shows the result.
  • the horizontal axis represents the concentration ( ⁇ M) of compound 10
  • the vertical axis represents the survival rate of cells.
  • the compound 10 is described as QCy (MeBT) 3 .
  • compound 10 is preferably used at 1 ⁇ M or less for living cells.
  • the quadruplex nucleic acid and the double-stranded nucleic acid in the living cells were stained using "2.3 Method for producing compound” and the compound 10 synthesized as shown in FIG.
  • compound 10 was dissolved in a 5% aqueous glucose solution and used as a staining solution.
  • the concentration of compound 10 in the staining solution was 1 ⁇ M.
  • the medium was removed from the cultured cells (HeLa cells), washed with a 5% aqueous glucose solution, a staining solution containing compound 10 was added, and the cells were incubated at 37 ° C. for 10 minutes. After washing with a 5% aqueous glucose solution, fluorescence microscopy (Ex 470/40, DM 495, Em 605/70; Ex 560/40, DM 585, Em 700/75) was performed.
  • FIG. 22 and 23 show the results of the sixth experiment.
  • “A” is a phase difference observation image (Ph) of cells.
  • the fluorescent image of "B” shows that the double chain DNA present in the cell nucleus of the cell shown in “A” is stained with 600 nm fluorescence.
  • the fluorescent image of "C” shows that the quadruplex DNA and quadruple RNA present in the cell nucleus of the cell shown in “A” are stained with 700 nm fluorescence.
  • “D” is a superposition of “B” and “C”
  • “E” is an enlarged image of "A”
  • “F” is an enlarged image of "B”
  • “G” is an enlarged image of "C”
  • “H” is an enlarged image of "D”.
  • both the quadruplex nucleic acid and the double-stranded nucleic acid in the living cell can be stained simultaneously and with different color fluorescence in the living cell as well as the fixed cell.
  • FIG. 23 shows the intensity and intensity difference ( ⁇ int.) Of 700 nm fluorescence and 600 nm fluorescence in the three cells (I-1, J-1, K-1) arbitrarily picked up from “D” in FIG. 22. ) Is shown.
  • I-2, J-2, and K-2 of FIG. 23 the Position on the horizontal axis indicates the position along the white line with respect to the position S of I-1, J-1, and K-1.
  • FIG. 24 shows phase difference observation images (Ph) of HeLa cells (live cells) stained with compound 10 when PDS was added (PDS (+)) and when PDS was not added (PDS ( ⁇ )). ) And the fluorescence image (600 nm fluorescence image, 700 nm fluorescence image) with time.
  • FIG. 25 shows the response (change in fluorescence intensity) to PDS of each of the four types of living cells (HeLA, A549, HEK2933, MRC-5) stained with compound 10. Also in FIG. 25, when PDS is added to living cells stained with compound 10, it is represented by PDS (+), and when it is not added, it is represented by PDS ( ⁇ ). In FIG. 25, the vertical axis represents the intensity ratio of 600 nm fluorescence and 700 nm fluorescence, and the horizontal axis represents the time after the addition of PDS.
  • the solvent of the staining solution (probe solution) containing the compound 10 a liquid having substantially no ion bound to the compound 10, such as H20 or 5 % glucose, is preferable.
  • a solvent having ions bound to compound 10 for example, PBS
  • the solvent is preferably one having an osmotic pressure substantially equal to that of cells, such as 5% glucose. The osmotic pressure is substantially equal to that of the cell, which protects the cell.
  • FIG. 27 shows the result.
  • “Ph” is a phase difference observation image of cells at each concentration of Hoechist 33258.
  • “Hoe” is a fluorescence image at 460 nm at each concentration of Hoechist 33258.
  • the fluorescence wavelength of Hoechist 33258 is 460 nm.
  • “600 nm” is a 600 nm fluorescence image.
  • “700 nm” is a 700 nm fluorescence image.
  • “600 nm / 700 nm” is a composite image of "600 nm” and “700 nm”.
  • "Magnified 600 nm / 700 nm” is an enlarged image of "600 nm / 700 nm”.
  • FIG. 28 shows the result.
  • “600 nm” is a 600 nm fluorescence image.
  • “700 nm” is a 700 nm fluorescence image.
  • “Hoe” is a fluorescence image at 460 nm at each concentration of Hoechist 33258.
  • “Merged” is a composite image of "600 nm", “700 nm” and "Hoe”.
  • the fluorescence intensity at 600 nm in the living cells decreased significantly. This indicates that the binding sites of compound 10 and Hoechist 33258 are in competition. That is, it was found that the compound 10 binds to the double chain DNA like Hoechist 33258 and emits fluorescence at 600 nm. Therefore, it was clarified that the double-stranded DNA in the living cell could be visualized by observing the fluorescence at 600 nm derived from the compound 10.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PCT/JP2021/043996 2020-12-11 2021-11-30 核酸検出方法、化合物、及び蛍光プローブ Ceased WO2022124148A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022568211A JP7773214B2 (ja) 2020-12-11 2021-11-30 核酸検出方法、化合物、及び蛍光プローブ
EP21903252.1A EP4261209A4 (en) 2020-12-11 2021-11-30 NUCLEIC ACID DETECTION METHOD, COMPOUND AND FLUORESCENT PROBE
US18/266,187 US20240301472A1 (en) 2020-12-11 2021-11-30 Nucleic acid detection method, compound and fluorescent probe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-206368 2020-12-11
JP2020206368 2020-12-11

Publications (1)

Publication Number Publication Date
WO2022124148A1 true WO2022124148A1 (ja) 2022-06-16

Family

ID=81973910

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/043996 Ceased WO2022124148A1 (ja) 2020-12-11 2021-11-30 核酸検出方法、化合物、及び蛍光プローブ

Country Status (4)

Country Link
US (1) US20240301472A1 (cg-RX-API-DMAC7.html)
EP (1) EP4261209A4 (cg-RX-API-DMAC7.html)
JP (1) JP7773214B2 (cg-RX-API-DMAC7.html)
WO (1) WO2022124148A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116768821A (zh) * 2023-06-25 2023-09-19 井冈山大学 一种植物提取物改性分子探针及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017033163A1 (en) * 2015-08-26 2017-03-02 Jawaharlal Nehru Centre For Advanced Scientific Research Compounds as stimuli-responsive probes, methods and applications thereof
WO2017033162A1 (en) * 2015-08-26 2017-03-02 Jawaharlal Nehru Centre For Advanced Scientific Research Compounds as dna probes, methods and applications thereof
JP2020176108A (ja) * 2019-04-22 2020-10-29 国立大学法人東京農工大学 グアニン四重鎖結合性リガンド

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017033163A1 (en) * 2015-08-26 2017-03-02 Jawaharlal Nehru Centre For Advanced Scientific Research Compounds as stimuli-responsive probes, methods and applications thereof
WO2017033162A1 (en) * 2015-08-26 2017-03-02 Jawaharlal Nehru Centre For Advanced Scientific Research Compounds as dna probes, methods and applications thereof
US10683273B2 (en) 2015-08-26 2020-06-16 Jawaharlal Nehru Centre For Advanced Scientific Research Compounds as DNA probes, methods and applications thereof
JP2020176108A (ja) * 2019-04-22 2020-10-29 国立大学法人東京農工大学 グアニン四重鎖結合性リガンド

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
NAAMA KARTON-LIFSHIN ET AL.: "Donor-Two-Acceptor'' Dye Design: A Distinct Gateway to NIR Fluorescence", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, pages 20412 - 20420, XP055306936, DOI: 10.1021/ja308124q
NAGARJUN NARAYANASWAMY ET AL.: "Sequence-specific recognition of DNA minor groove by an NIR-fluorescence switch-on probe and its potential applications", NUCLEIC ACIDS RESEARCH, vol. 43, no. 18, 2015, pages 8651 - 8663, XP055328442, DOI: 10.1093/nar/gkv875
NAGARJUN NARAYANASWAMY, SHUBHAJIT DAS, PRALOK K. SAMANTA, KHADIJA BANU, GURU PRASAD SHARMA, NEELIMA MONDAL, SUMAN K. DHAR, SWAPAN : "Sequence-specific recognition of DNA minor groove by an NIR-fluorescence switch-on probe and its potential applications", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 43, no. 18, 15 October 2015 (2015-10-15), GB , pages 8651 - 8663, XP055328442, ISSN: 0305-1048, DOI: 10.1093/nar/gkv875 *
SAKAMOTO, TAKASHI; YU, ZEHUI; OTANI, YUTO: "A23-1am-03 Simultaneous detection of double-stranded and G4 DNA with tripodal quinone-cyanine dye", PROCEEDINGS OF SPRING MEETING OF THE CHEMICAL SOCIETY OF JAPAN (CSJ), vol. 101, 19 March 2021 (2021-03-19) - 22 March 2021 (2021-03-22), JP, XP009537400 *
See also references of EP4261209A4

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116768821A (zh) * 2023-06-25 2023-09-19 井冈山大学 一种植物提取物改性分子探针及其制备方法和应用
WO2025000859A1 (zh) * 2023-06-25 2025-01-02 井冈山大学 一种植物提取物改性分子探针及其制备方法和应用

Also Published As

Publication number Publication date
EP4261209A4 (en) 2025-07-02
US20240301472A1 (en) 2024-09-12
JP7773214B2 (ja) 2025-11-19
JPWO2022124148A1 (cg-RX-API-DMAC7.html) 2022-06-16
EP4261209A1 (en) 2023-10-18

Similar Documents

Publication Publication Date Title
JP4790598B2 (ja) メソ置換シアニン色素標識化試薬
JP4943156B2 (ja) シアニン色素標識用試薬
Yan et al. Amino (oligo) thiophene-based environmentally sensitive biomembrane chromophores
JP5526124B2 (ja) 近赤外蛍光化合物
RU2018138590A (ru) Ультраяркие димерные или полимерные красители со спейсерными линкерными группами
US11597842B2 (en) Labeling dye and kit including same
US20040260093A1 (en) Compound, especially marker-dye on the basis of polymethines
Bora et al. Diazaoxatriangulenium: synthesis of reactive derivatives and conjugation to bovine serum albumin
WO2015151071A2 (en) Small molecular probes, processes and use thereof
US20030165942A1 (en) Compound, especially marker-dye, on the basis of polymethines
CN114040962A (zh) 用于细胞器成像的发射红色荧光的化合物
Krawczyk et al. Spectroscopic and nonlinear optical properties of new chalcone fluorescent probes for bioimaging applications: a theoretical and experimental study
Lou et al. Detection of adenine-rich ssDNA based on thymine-substituted tetraphenylethene with aggregation-induced emission characteristics
US20250084250A1 (en) Azaindole cyanine dyes, uses, and methods of preparation
CN102702769B (zh) 一类绿光荧光菁染料、制备方法及其应用
CN105038295A (zh) 一种基于菁染料为骨架的近红外荧光化合物、制备及其应用
CN111334078B (zh) 一种405nm激发的高亮度、高稳定性荧光染料及其合成方法
JP7773214B2 (ja) 核酸検出方法、化合物、及び蛍光プローブ
Patalag et al. Rational design of Fluorophores using MO Theory: our Journey from BODIPYs to BOIMPYs
JP2010505991A (ja) フルオロ置換ベンゾオキサゾールポリメチン色素
US7351829B2 (en) Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use
Cao et al. Modulation of G4 DNA sensing behavior by triphenylamine-imidazole based DD-π-A-type organic fluorophores with subtle structural change
CN102093270A (zh) 细胞内银离子检测用二苯代乙烯双光子荧光探针
Gupta et al. Design and development of fluorescence-capable novel pyrazine-based polycyclic heteroaromatics for cellular bioimaging
Adak et al. An Emission‐Based Probe for the Detection and Quantification of DNA and RNA

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21903252

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022568211

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 18266187

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2021903252

Country of ref document: EP

Effective date: 20230711